SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)
29.70
0.00 (0.00%)
At close: May 29, 2025, 5:30 PM CET
BIT:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 252.33M EUR in the quarter ending March 31, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 972.81M, up 6.16% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.
Revenue (ttm)
972.81M
Revenue Growth
+6.16%
P/S Ratio
4.32
Revenue / Employee
203.09K
Employees
4,690
Market Cap
4.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UniCredit | 24.19B |
Intesa Sanpaolo | 25.43B |
Enel SpA | 78.35B |
Ferrari | 6.88B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 90.96B |
Leonardo S.p.a. | 18.26B |
Stellantis | 156.88B |